Animal Genetics Market Overview
The global Animal Genetics Market is experiencing significant growth as livestock producers increasingly adopt advanced breeding technologies and precision genomic solutions. Valued at USD 6.44 billion in 2023, the market is projected to reach USD 11.47 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.62% from 2024 to 2032. This growth is being powered by rising demand for high-yielding, disease-resistant livestock and increasing investments in artificial reproductive technologies (ART), including artificial insemination (AI), embryo transfer (ET), and in-vitro fertilization (IVF).
A key growth driver for the animal genetics industry is the escalating demand for food production efficiency amid global population growth and climate change challenges. This has compelled livestock producers to integrate genetics-driven strategies into their breeding programs to boost meat and dairy yields, improve disease resistance, and enhance overall animal productivity.
Get a Free Sample Report of Animal Genetics Market@ https://www.snsinsider.com/sample-request/2879
Technological advancements in ART and genomic testing have made it easier for producers to track and select traits with greater accuracy, accelerating the breeding of healthier and more efficient animals. Companies like Genus Plc and Zoetis, Inc. have made substantial strides in developing ART-based platforms, making these technologies more accessible to farmers around the globe.
Another growth catalyst is the increasing support for sustainable animal farming, particularly in regions like Europe, where animal welfare regulations and environmental mandates are pushing breeders to adopt precision breeding approaches. These strategies not only improve animal health and longevity but also align with sustainability and carbon reduction goals.
Animal Genetics Market Segment Analysis:
The ART segment dominated the global animal genetics market in 2023, capturing approximately 52% of the revenue share. This segment’s prominence stems from the rapid adoption of artificial insemination and embryo transfer technologies. With ART becoming increasingly sophisticated, genetic selection can now be fine-tuned to target traits such as fertility, growth rate, and disease resistance.
Major market players are deepening their ART portfolios to enhance breeding efficiency. For example, Zoetis recently introduced a suite of ART-based genetic selection tools that integrate seamlessly with farm management software, offering breeders real-time insights and predictive modeling capabilities.
On the application front, cattle genetics emerged as the most dominant segment, accounting for an estimated 44% of market share. This trend reflects the rising global demand for premium-quality dairy and meat products. As a result, companies like Neogen Corporation and URUS are deploying genomic testing platforms tailored to cattle, aimed at improving traits such as milk yield, feed conversion efficiency, and resistance to infectious diseases.
Advanced genetic evaluation tools that combine marker-assisted selection and AI have enabled cattle breeders to make faster and more reliable genetic gains. These tools are increasingly being adopted by farms of all sizes, further stimulating growth in this segment.
Distribution Channel Outlook:
The private distribution channel is anticipated to lead the market over the forecast period, accounting for nearly 68% of market share. The dominance of this channel is underpinned by the growing participation of private biotechnology firms, breeding service providers, and AI technology developers.
Organizations such as Hendrix Genetics and Topigs Norsvin have expanded their global footprints by offering tailored breeding services directly to livestock farmers. These include on-site AI programs, mobile genomics testing, and advisory services for genetic program design. Private-sector engagement has significantly improved access to animal genetics services, especially for mid-sized and small-scale livestock operations in both developed and developing regions.
Animal Genetics Market Regional Insights:
North America held the largest regional market share at 38% in 2023 and is expected to maintain its leadership through 2032. The United States and Canada are at the forefront of adopting advanced animal breeding technologies and genomic research initiatives. Leading players such as Zoetis and Neogen Corporation have been instrumental in rolling out next-generation solutions for animal health and genetics.
The robust livestock farming infrastructure, especially in dairy and beef cattle, combined with strong government and private-sector investments in research and development, has helped reinforce North America’s leadership in the animal genetics space. The region’s emphasis on genomic testing integration with herd management systems has also streamlined genetic decision-making at the farm level.
Europe follows closely with a significant share, driven by strong regulatory support for sustainable farming practices and animal welfare. Countries such as Germany, France, and the Netherlands are adopting genomic selection and AI tools at scale. Hendrix Genetics and Neogen have launched several genomic testing products for swine and poultry, helping enhance breed resilience and productivity.
European livestock producers are embracing precision breeding not just for economic gains but to comply with stringent EU sustainability and traceability standards. These shifts are creating new market opportunities and fostering a supportive environment for innovation in livestock genetics.
Need Any Customization Research on Animal Genetics Market, Enquire Now@ https://www.snsinsider.com/enquiry/2879
Competitive Landscape:
The animal genetics market is highly competitive, with a mix of global biotechnology firms, genomic solution providers, and livestock breeding companies. Key players include Genus Plc, Envigo Corporation, Topigs Norsvin, CRV Holding B.V., Groupe Grimaud La Corbiere SA, Hendrix Genetics BV, Neogen Corporation, Zoetis Inc., URUS, and Animal Genetics, Inc.
These companies are continuously investing in product innovation, strategic partnerships, and global expansion to enhance their market presence. Semex, STgenetics, VikingGenetics, and ABS Global are also playing critical roles in introducing novel breeding tools like sexed semen technologies, genomic selection indices, and real-time reproductive analytics.
In a recent development that underscores the industry’s focus on sustainability, SCHOTT Pharma, in collaboration with Schreiner MediPharm and Körber Pharma, unveiled a blister-free syringe packaging solution in October 2024. This innovative packaging, made from 100% cardboard mono-material, aims to cut plastic waste and lower carbon emissions, signaling a broader industry shift towards eco-friendly practices.
Similarly, in October 2023, SCHOTT AG introduced FIOLAX Pro, a next-generation borosilicate glass tubing designed for the pharmaceutical industry. This innovation enhances chemical durability and supports complex drug formulations—an example of how cross-sector advancements can influence standards across healthcare and life sciences, including veterinary genetics.
Animal Genetics Market Outlook:
The outlook for the animal genetics market remains robust as the world grapples with the challenges of ensuring food security, sustainability, and animal health. The integration of digital tools, AI-based breeding solutions, and genomic profiling is revolutionizing how livestock are bred, managed, and optimized for performance.
As demand for premium meat, milk, and genetic diversity grows, the need for high-quality and ethically bred livestock will intensify. Companies that prioritize innovation, data-driven breeding practices, and environmental stewardship are likely to gain competitive advantage in the coming years.
With continuous technological advancement, increased government support for genetic research, and greater awareness among producers regarding the benefits of genetic optimization, the global animal genetics market is poised for sustained growth through 2032.
Read Our Other Report
Wearable Drug Delivery Devices Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave – Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
